Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 18 | 2023 | 153 | 3.380 |
Why?
|
| Atrial Appendage | 5 | 2022 | 40 | 1.880 |
Why?
|
| Catheter Ablation | 12 | 2021 | 74 | 1.650 |
Why?
|
| Pacemaker, Artificial | 7 | 2023 | 25 | 1.250 |
Why?
|
| Cardiac Pacing, Artificial | 7 | 2022 | 31 | 0.960 |
Why?
|
| Pulmonary Veins | 5 | 2020 | 32 | 0.850 |
Why?
|
| Cardiac Catheterization | 2 | 2018 | 63 | 0.760 |
Why?
|
| Stroke | 4 | 2022 | 260 | 0.750 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2020 | 83 | 0.710 |
Why?
|
| Heart Transplantation | 1 | 2018 | 24 | 0.630 |
Why?
|
| Bundle of His | 4 | 2022 | 25 | 0.570 |
Why?
|
| Cryosurgery | 3 | 2020 | 22 | 0.530 |
Why?
|
| Defibrillators, Implantable | 3 | 2023 | 12 | 0.500 |
Why?
|
| Treatment Outcome | 13 | 2022 | 3391 | 0.480 |
Why?
|
| Heart Failure | 3 | 2020 | 181 | 0.430 |
Why?
|
| Humans | 35 | 2023 | 26286 | 0.400 |
Why?
|
| Electric Injuries | 1 | 2011 | 1 | 0.390 |
Why?
|
| Intercostal Muscles | 1 | 2011 | 2 | 0.390 |
Why?
|
| Spasm | 1 | 2011 | 2 | 0.390 |
Why?
|
| Transposition of Great Vessels | 2 | 2008 | 4 | 0.340 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2018 | 38 | 0.320 |
Why?
|
| Heart Defects, Congenital | 1 | 2008 | 27 | 0.310 |
Why?
|
| Risk Factors | 8 | 2022 | 2265 | 0.290 |
Why?
|
| Heart Rate | 4 | 2020 | 108 | 0.280 |
Why?
|
| Male | 18 | 2023 | 14162 | 0.280 |
Why?
|
| Electric Countershock | 1 | 2005 | 10 | 0.260 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2021 | 37 | 0.250 |
Why?
|
| Thrombosis | 2 | 2018 | 52 | 0.240 |
Why?
|
| Aged | 12 | 2021 | 8765 | 0.240 |
Why?
|
| Registries | 3 | 2021 | 177 | 0.240 |
Why?
|
| Action Potentials | 3 | 2020 | 116 | 0.230 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2021 | 19 | 0.230 |
Why?
|
| Heart Ventricles | 2 | 2022 | 123 | 0.230 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 4 | 0.220 |
Why?
|
| Anticoagulants | 2 | 2018 | 89 | 0.210 |
Why?
|
| Prosthesis Implantation | 2 | 2016 | 31 | 0.210 |
Why?
|
| Electrocoagulation | 1 | 2022 | 12 | 0.200 |
Why?
|
| Atrial Flutter | 3 | 2011 | 4 | 0.200 |
Why?
|
| Equipment Design | 2 | 2021 | 144 | 0.200 |
Why?
|
| Retrospective Studies | 9 | 2023 | 3367 | 0.200 |
Why?
|
| Risk Assessment | 5 | 2020 | 629 | 0.200 |
Why?
|
| Bradycardia | 1 | 2021 | 25 | 0.190 |
Why?
|
| Time Factors | 6 | 2021 | 1391 | 0.190 |
Why?
|
| Metabolic Equivalent | 1 | 2020 | 5 | 0.180 |
Why?
|
| Middle Aged | 12 | 2020 | 8601 | 0.180 |
Why?
|
| Septal Occluder Device | 1 | 2020 | 12 | 0.180 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 33 | 0.180 |
Why?
|
| Female | 15 | 2023 | 14539 | 0.180 |
Why?
|
| Radiation Exposure | 1 | 2020 | 9 | 0.170 |
Why?
|
| Radiography, Interventional | 1 | 2020 | 22 | 0.170 |
Why?
|
| Radiation Dosage | 1 | 2020 | 36 | 0.170 |
Why?
|
| Ventricular Premature Complexes | 1 | 2019 | 2 | 0.170 |
Why?
|
| Heparin Antagonists | 1 | 2019 | 1 | 0.170 |
Why?
|
| Protamines | 1 | 2019 | 3 | 0.170 |
Why?
|
| Hemostasis | 1 | 2019 | 8 | 0.170 |
Why?
|
| Heparin | 1 | 2019 | 19 | 0.170 |
Why?
|
| Adult | 7 | 2021 | 7448 | 0.170 |
Why?
|
| Hemorrhage | 1 | 2019 | 78 | 0.160 |
Why?
|
| Punctures | 1 | 2018 | 10 | 0.160 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 26 | 0.160 |
Why?
|
| Image Enhancement | 1 | 2018 | 46 | 0.160 |
Why?
|
| Suture Techniques | 1 | 2019 | 150 | 0.160 |
Why?
|
| Electrodes, Implanted | 2 | 2008 | 26 | 0.160 |
Why?
|
| Bundle-Branch Block | 1 | 2018 | 9 | 0.160 |
Why?
|
| Contrast Media | 1 | 2018 | 60 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 46 | 0.160 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 2 | 0.150 |
Why?
|
| Ventricular Fibrillation | 2 | 2016 | 14 | 0.150 |
Why?
|
| Computer Security | 1 | 2018 | 4 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2018 | 57 | 0.150 |
Why?
|
| Policy Making | 1 | 2017 | 14 | 0.150 |
Why?
|
| Azygos Vein | 1 | 2017 | 3 | 0.150 |
Why?
|
| Incidental Findings | 1 | 2017 | 12 | 0.150 |
Why?
|
| Stroke Volume | 3 | 2023 | 62 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2017 | 9 | 0.150 |
Why?
|
| Recurrence | 4 | 2020 | 314 | 0.140 |
Why?
|
| Consensus | 1 | 2017 | 83 | 0.140 |
Why?
|
| Cardiology | 1 | 2017 | 44 | 0.140 |
Why?
|
| Societies, Medical | 1 | 2017 | 146 | 0.130 |
Why?
|
| Exercise | 1 | 2020 | 451 | 0.130 |
Why?
|
| Intraoperative Care | 1 | 2016 | 39 | 0.130 |
Why?
|
| Electrocardiography | 3 | 2022 | 112 | 0.100 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2011 | 10 | 0.100 |
Why?
|
| Heart Atria | 1 | 2011 | 61 | 0.090 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2010 | 9 | 0.090 |
Why?
|
| Telemetry | 1 | 2010 | 10 | 0.090 |
Why?
|
| Ischemic Attack, Transient | 1 | 2010 | 19 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2021 | 210 | 0.090 |
Why?
|
| Coronary Occlusion | 1 | 2010 | 1 | 0.090 |
Why?
|
| Fluoroscopy | 2 | 2020 | 53 | 0.090 |
Why?
|
| Exercise Test | 2 | 2020 | 120 | 0.080 |
Why?
|
| Brain Ischemia | 1 | 2010 | 60 | 0.080 |
Why?
|
| Coronary Angiography | 2 | 2010 | 72 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 1 | 2009 | 24 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2009 | 34 | 0.080 |
Why?
|
| Cardiac Electrophysiology | 1 | 2008 | 2 | 0.080 |
Why?
|
| Iliac Vein | 1 | 2008 | 3 | 0.080 |
Why?
|
| Equipment Failure | 1 | 2008 | 37 | 0.080 |
Why?
|
| Pericardium | 1 | 2008 | 18 | 0.080 |
Why?
|
| Torsades de Pointes | 1 | 2007 | 7 | 0.070 |
Why?
|
| Long QT Syndrome | 1 | 2007 | 7 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 4675 | 0.070 |
Why?
|
| Amiodarone | 1 | 2005 | 1 | 0.060 |
Why?
|
| International Normalized Ratio | 1 | 2005 | 19 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 32 | 0.060 |
Why?
|
| Warfarin | 1 | 2005 | 26 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 1668 | 0.060 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 42 | 0.050 |
Why?
|
| United States | 2 | 2019 | 1990 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2022 | 16 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 333 | 0.050 |
Why?
|
| Thermography | 1 | 2021 | 14 | 0.050 |
Why?
|
| Temperature | 1 | 2021 | 58 | 0.050 |
Why?
|
| Swine | 1 | 2021 | 65 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2021 | 57 | 0.050 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 5 | 0.050 |
Why?
|
| Hyperthyroidism | 1 | 2020 | 7 | 0.050 |
Why?
|
| Heart Valve Diseases | 1 | 2020 | 16 | 0.050 |
Why?
|
| Electrophysiological Phenomena | 1 | 2020 | 11 | 0.050 |
Why?
|
| Lasers | 1 | 2020 | 18 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 159 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 311 | 0.040 |
Why?
|
| Alcoholism | 1 | 2020 | 64 | 0.040 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 53 | 0.040 |
Why?
|
| Hemostatic Techniques | 1 | 2019 | 7 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 49 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2020 | 149 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 378 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 89 | 0.040 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2018 | 6 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 133 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 347 | 0.040 |
Why?
|
| Hypertension | 1 | 2020 | 223 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 716 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 753 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 687 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 279 | 0.040 |
Why?
|
| Phlebography | 1 | 2017 | 9 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 29 | 0.040 |
Why?
|
| Myocardial Infarction | 2 | 2010 | 136 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 679 | 0.030 |
Why?
|
| Reoperation | 1 | 2020 | 879 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 1886 | 0.030 |
Why?
|
| Animals | 1 | 2021 | 3538 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 485 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 52 | 0.020 |
Why?
|
| Epicardial Mapping | 1 | 2009 | 2 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2010 | 36 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 460 | 0.020 |
Why?
|
| Autopsy | 1 | 2010 | 340 | 0.020 |
Why?
|
| Hospitalization | 1 | 2010 | 294 | 0.020 |
Why?
|
| Chicago | 1 | 2010 | 843 | 0.020 |
Why?
|
| Adolescent | 1 | 2009 | 2080 | 0.010 |
Why?
|
| Length of Stay | 1 | 2005 | 304 | 0.010 |
Why?
|